Vagus Nerve Stimulation for the Therapy of Dravet Syndrome: a Systematic Review and Meta-analysis

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Jul 24

PMID 39045432

Authors

Shuang Chen

Man Li

Ming Huang

Affiliations

Soon will be listed here.

Abstract

Objective: Dravet syndrome (DS) is a refractory developmental and epileptic encephalopathy characterized by seizures, developmental delay and cognitive impairment with a variety of comorbidities, including autism-like behavior, speech dysfunction, and ataxia. Vagus nerve stimulation (VNS) is one of the common therapies for DS. Here, we aim to perform a meta-analysis and systematic review of the efficacy of VNS in DS patients.

Methods: We systematically searched four databases (PubMed, Embase, Cochrane and CNKI) to identify potentially eligible studies from their inception to January 2024. These studies provided the effective rate of VNS in treating patients with DS. The proportions of DS patients achieving ≥50% reduction of seizure frequency were extracted from these studies. Meta-analyses were performed to respectively evaluate the efficacy of VNS for DS after 3, 6, 12, 18, 24 and 36 months.

Results: Sixteen trials with a total of 173 patients were included. Meta-analyses showed that the pooled efficiency was 0.54 (95% CI 0.43-0.65) in the DS patients treated with VNS ( < 0.05). Meanwhile, the pooled efficiency respectively was 0.42 (95% CI 0.25-0.61), 0.54 (95% CI 0.39-0.69), 0.51 (95% CI 0.39-0.66), and 0.49 (95% CI 0.36-0.63) in the DS patients treated with VNS after 3, 6, 12 and 24 months ( < 0.05).

Conclusion: This study suggests that VNS is effective in the treatment of DS. However, few studies have focused on VNS for DS, and there is a lack of high-quality evidence. Thus, high-quality randomized controlled trials are needed to confirm the efficacy of VNS in DS.

References

Hajtovic S, LoPresti M, Zhang L, Katlowitz K, Kizek D, Lam S . The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis. J Neurosurg Pediatr. 2022; 29(6):667-680. DOI: 10.3171/2022.1.PEDS222. View

Youn S, Jung D, Kang H, Kim H . Long-term results of vagus nerve stimulation in children with Dravet syndrome: Time-dependent, delayed antiepileptic effect. Epilepsy Res. 2021; 174:106665. DOI: 10.1016/j.eplepsyres.2021.106665. View

Arya R, Greiner H, Lewis A, Horn P, Mangano F, Gonsalves C . Predictors of response to vagus nerve stimulation in childhood-onset medically refractory epilepsy. J Child Neurol. 2013; 29(12):1652-9. DOI: 10.1177/0883073813510970. View

Maleknia P, McWilliams T, Barkley A, Estevez-Ordonez D, Rozzelle C, Blount J . Postoperative seizure freedom after vagus nerve stimulator placement in children 6 years of age and younger. J Neurosurg Pediatr. 2023; 31(4):329-332. DOI: 10.3171/2022.12.PEDS22302. View

Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D . Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia. 2014; 55(10):1576-84. DOI: 10.1111/epi.12762. View

Lagae L, Verstrepen A, Nada A, van Loon J, Theys T, Ceulemans B . Vagus nerve stimulation in children with drug-resistant epilepsy: age at implantation and shorter duration of epilepsy as predictors of better efficacy?. Epileptic Disord. 2015; 17(3):308-14. DOI: 10.1684/epd.2015.0768. View

Dressler A, Trimmel-Schwahofer P, Reithofer E, Muhlebner A, Groppel G, Reiter-Fink E . Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen. Epilepsy Res. 2014; 109:81-9. DOI: 10.1016/j.eplepsyres.2014.10.014. View

Sparber P, Bychkov I, Pyankov D, Skoblov M . Functional investigation of SCN1A deep-intronic variants activating poison exons inclusion. Hum Genet. 2023; 142(8):1043-1053. DOI: 10.1007/s00439-023-02564-y. View

Zhang L, Li W, Wang C . Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta-analysis. Acta Neurol Scand. 2020; 143(4):339-348. DOI: 10.1111/ane.13387. View

10.

Chrastina J, Kocvarova J, Novak Z, Dolezalova I, Svoboda M, Brazdil M . Older Age and Longer Epilepsy Duration Do Not Predict Worse Seizure Reduction Outcome after Vagus Nerve Stimulation. J Neurol Surg A Cent Eur Neurosurg. 2017; 79(2):152-158. DOI: 10.1055/s-0037-1607396. View

11.

Brunklaus A, Zuberi S . Dravet syndrome--from epileptic encephalopathy to channelopathy. Epilepsia. 2014; 55(7):979-84. DOI: 10.1111/epi.12652. View

12.

Cersosimo R, Bartuluchi M, Fortini S, Soraru A, Pomata H, Caraballo R . Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord. 2012; 13(4):382-8. DOI: 10.1684/epd.2011.0479. View

13.

Wang Z, Kim E, Noh B, Liang J, Lee D, Hur Y . Alteration in brain connectivity in patients with Dravet syndrome after vagus nerve stimulation (VNS): exploration of its effectiveness using graph theory analysis with electroencephalography. J Neural Eng. 2020; 17(3):036014. DOI: 10.1088/1741-2552/ab914f. View

14.

Skrehot H, Englot D, Haneef Z . Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis. Epilepsy Behav. 2023; 142:109182. DOI: 10.1016/j.yebeh.2023.109182. View

15.

Zamponi N, Passamonti C, Cappanera S, Petrelli C . Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur J Paediatr Neurol. 2010; 15(1):8-14. DOI: 10.1016/j.ejpn.2010.09.003. View

16.

Fulton S, Van Poppel K, McGregor A, Mudigoudar B, Wheless J . Vagus Nerve Stimulation in Intractable Epilepsy Associated With SCN1A Gene Abnormalities. J Child Neurol. 2017; 32(5):494-498. DOI: 10.1177/0883073816687221. View

17.

Goff K, Liebergall S, Jiang E, Somarowthu A, Goldberg E . VIP interneuron impairment promotes in vivo circuit dysfunction and autism-related behaviors in Dravet syndrome. Cell Rep. 2023; 42(6):112628. PMC: 10592464. DOI: 10.1016/j.celrep.2023.112628. View

18.

Dibue M, Greco T, Spoor J, Tahir Z, Specchio N, Hanggi D . Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis. Acta Neurol Scand. 2020; 143(5):497-508. PMC: 8049065. DOI: 10.1111/ane.13375. View

19.

Wang H, Tan G, Zhu L, Chen D, Xu D, Chu S . Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy. Seizure. 2019; 66:53-60. DOI: 10.1016/j.seizure.2019.02.010. View

20.

Colicchio G, Policicchio D, Barbati G, Cesaroni E, Fuggetta F, Meglio M . Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration. Childs Nerv Syst. 2010; 26(6):811-9. DOI: 10.1007/s00381-009-1069-2. View